Press release |

27 July 2018

Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

South Africa breaks the ‘silence’ period and negotiations are re-opened

Tuberculosis

Latest news

Feature story |

31 July 2018

Chronicles of a Surgery, Armenia.

Press release |

27 July 2018

Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

South Africa breaks the ‘silence’ period and negotiations are re-opened

Letter |

25 July 2018

MSF Access calls on Gilead to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

Letter |

24 July 2018

MSF calls on Mylan to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

Press release |

23 July 2018

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

MSF calls out ViiV Healthcare—a division of US and UK pharmaceutical corporations Pfizer and GlaxoSmithKline plus Japan’s Shionogi—for preventing children with HIV from getting child-appropriate formulations of a critical HIV medicine, dolutegravir.

Feature story |

23 July 2018

Meeting the specific needs of key populations living with HIV – MSF’s experience

Issue briefTechnical brief |

23 July 2018

Stopping senseless deaths

This technical brief analyses access barriers to affordable, lifesaving diagnostics and treatments for HIV and OIs, including adult and paediatric formulations of dolutegravir – a highly effective and tolerable HIV integrase inhibitor that replaces efavirenz in first-line treatment regimens. Updated antiretroviral (ARV) drug pricing information is also provided.

Press release |

20 July 2018

At last minute, countries pressured to drop language on protecting access to affordable medicines from TB Summit declaration negotiations

Press release |

20 July 2018

ASEAN and India urged not to trade away people’s lives in trade agreement

RCEP trade deal could cut medicines lifeline for people in developing countries

Letter |

19 July 2018

MSF calls on ViiV to urgently step up efforts to ensure widespread access to dolutegravir for children

MSF and over 30 organisations signed a letter urging the company to make its medicine available to the children who need it.

Feature story |

19 July 2018

The outcome of the two years mass vaccination campaign in Central African Republic

Protecting as many children as possible in an emergency context

Technical brief |

09 July 2018

India

The grounds for opposing patent applications for velpatasvir

What good is a breakthrough medicine if the people who need it can't afford it?

Video

A Snapshot of the Access Campaign

Our work

Drug-resistant infections

Hepatitis C

HIV/AIDS

Tropical & neglected diseases

Tuberculosis

Vaccines

Patents & intellectual property

Research & development

Read, watch, share

Issue brief |

07 May 2018

Access Campaign Year in Review 2017

Vaccines

A Fair Shot

Give children a fair shot

Feature story

Feature story |

31 July 2018

Tuberculosis

Armenia

Chronicles of a Surgery, Armenia.

Feature story

Feature story |

23 July 2018

HIV/AIDS

MalawiMozambiqueIndia

Meeting the specific needs of key populations living with HIV – MSF’s experience

6 min

Issue brief

Technical brief |

23 July 2018

HIV/AIDS

Stopping senseless deaths

Funny time during the "six-month-day meeting" in Mbulumbuzi Health Centre, Malawi, 2017.

Photo story

HIV/AIDS

Malawi

HIV care for children and adolescents in Malawi

In Nsanje district, Malawi, MSF supports the severely underfunded district management team in running a fully decentralised HIV and tuberculosis (TB) programme that includes infants newly diagnosed with HIV.

Feature story

Feature story |

19 July 2018

Vaccines

Central African Republic

The outcome of the two years mass vaccination campaign in Central African Republic

Protecting as many children as possible in an emergency context

4 min

Photo story

Intellectual property and trade

South Africa

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Medicines shouldn’t be a luxury

A Fair Shot

Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

Latest news

Chronicles of a Surgery, Armenia.

Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

MSF Access calls on Gilead to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

MSF calls on Mylan to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

Meeting the specific needs of key populations living with HIV – MSF’s experience

Stopping senseless deaths

At last minute, countries pressured to drop language on protecting access to affordable medicines from TB Summit declaration negotiations

ASEAN and India urged not to trade away people’s lives in trade agreement

MSF calls on ViiV to urgently step up efforts to ensure widespread access to dolutegravir for children

The outcome of the two years mass vaccination campaign in Central African Republic

The grounds for opposing patent applications for velpatasvir

A Snapshot of the Access Campaign

Our work

Read, watch, share

Access Campaign Year in Review 2017

A Fair Shot

Chronicles of a Surgery, Armenia.

Meeting the specific needs of key populations living with HIV – MSF’s experience

Stopping senseless deaths

HIV care for children and adolescents in Malawi

The outcome of the two years mass vaccination campaign in Central African Republic

Fix the Patent Laws Campaign

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Public support helps expand access to life-saving care and treatment.

Homepage

Latest news

Chronicles of a Surgery, Armenia.

Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

MSF Access calls on Gilead to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

MSF calls on Mylan to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

Meeting the specific needs of key populations living with HIV – MSF’s experience

Stopping senseless deaths

At last minute, countries pressured to drop language on protecting access to affordable medicines from TB Summit declaration negotiations

ASEAN and India urged not to trade away people’s lives in trade agreement

MSF calls on ViiV to urgently step up efforts to ensure widespread access to dolutegravir for children

The outcome of the two years mass vaccination campaign in Central African Republic

The grounds for opposing patent applications for velpatasvir

Our work

Read, watch, share

Join the conversation

Don't miss out!